📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Medical Data Vision Co Ltd

Common Name
Medical Data Vision
Country
Japan
Sector
Healthcare
Industry
Health Information Services
Employees
315
Ticker
3902
Exchange
TOKYO STOCK EXCHANGE
Description
Medical Data Vision Co., Ltd. is a leading healthcare technology company that focuses on the management and analysis of medical data. The primary function of the company is to collect and utilize heal...

Medical Data Vision's GHG Emissions Data Preview

In 2024, Medical Data Vision completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Medical Data Vision has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=3902&reporting_period=2024"

Verified Sources Behind Medical Data Vision’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Medical Data Vision’s data sources below and access millions more through our Disclosure Search.

a. Medical Data Vision's Integrated Report 2025
a. Medical Data Vision's Integrated Report 2025

Insights into Medical Data Vision's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions ofMedical Data Vision amounted to292metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Medical Data Visionincreased by 37.74%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Medical Data Vision's Scope 1 Emissions Over Time

202320240481216tCO2e0%
  • Total Scope 1
  • Year-over-Year Change

What are Medical Data Vision's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Medical Data Vision were 13 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Compared to the previous year(2023), Medical Data Vision's Scope 1 emissions remained relatively stable, indicating that Medical Data Vision's emissions have plateaued with no significant change in its operational footprint.a

What are Medical Data Vision's Scope 2 emissions?

In 2024, Medical Data Vision reported Scope 2 greenhouse gas (GHG) emissions of 184 tCOâ‚‚e using the market-based method and 279 tCOâ‚‚e using the location-based method.a

What methodology does Medical Data Vision use for Scope 2 reporting?

In 2024, Medical Data Vision reported its Scope 2 emissions using the market-based method and using the location-based method.a

Medical Data Vision's Scope 2 Emissions Over Time

20232024070140210280tCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Medical Data Vision's Value Chain Emissions

In 2024, Medical Data Vision reported 4,724 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Medical Data Vision includes a breakdown across 9of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Medical Data Vision's Scope 3 Emissions Over Time

2023202401.5 k3 k4.5 k6 ktCO2e+50%
  • Total Scope 3
  • Year-over-Year Change

What are Medical Data Vision's Scope 3 emissions?

In 2024, Medical Data Vision reported total Scope 3 emissions of 4,724 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Approximately 95.42%of these emissions originated from upstream activities such as purchased goods and capital goods, while 4.58%came from downstream activities like product use, distribution, and end-of-life treatment.a

Compared to the previous year (2023), Medical Data Vision's Scope 3 emissions increased by 50.16%, suggesting that the company faced challenges in reducing emissions across its value chain.a

What categories of Scope 3 emissions does Medical Data Vision disclose?

In 2024, Medical Data Vision reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Medical Data Vision's Scope 3 emissions?

In 2024, the largest contributors to Medical Data Vision's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 3,542 tCOâ‚‚e(75.04%)
  • Business Travel (Cat. 6): 374 tCOâ‚‚e(7.92%)
  • Capital Goods (Cat. 2): 280 tCOâ‚‚e(5.93%)

Medical Data Vision's Scope 3 Emissions by Categories

Capital Goods(Cat. 2)(5.9%)Business Travel(Cat. 6)(7.9%)Purchased Goods andServices (Cat. 1)(75.0%)

Insights into Medical Data Vision’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Medical Data Vision reported Scope 1 greenhouse gas (GHG) emissions of 13 tCOâ‚‚e and total revenues of USD 38 millions. This translates into an emissions intensity of 0.35 tCOâ‚‚e per millions USD.a

Medical Data Vision's Scope 1 Emissions Intensity Compared to Peers

102002,00050,0001,000,000Scope 1 Emissions (tCO2e)201001,00010,000100,000Revenues (Millions of USD)PSNMMSysmexYear: 2024Scope 1: 13,449 tCO2eRevenue: $M 3,047Scope 1 Intensity: 4.41 tCO2e/$MPPPHC HoldingsYear: 2023Scope 1: 15,861 tCO2eRevenue: $M 2,676Scope 1 Intensity: 5.93 tCO2e/$MSSSugi HoldingsYear: 2023Scope 1: 1,531 tCO2eRevenue: $M 4,898Scope 1 Intensity: 0.31 tCO2e/$MOno PharmaceuticalYear: 2024Scope 1: 8,100 tCO2eRevenue: $M 3,319Scope 1 Intensity: 2.44 tCO2e/$MMatsukiyoCocokara & CoYear: 2024Scope 1: 3,764 tCO2eRevenue: $M 6,752Scope 1 Intensity: 0.56 tCO2e/$MChugai PharmaceuticalYear: 2024Scope 1: 51,143 tCO2eRevenue: $M 7,456Scope 1 Intensity: 6.86 tCO2e/$MSuzukenYear: 2024Scope 1: 26,205 tCO2eRevenue: $M 15,759Scope 1 Intensity: 1.66 tCO2e/$MTsuruha HoldingsYear: 2023Scope 1: 3,424 tCO2eRevenue: $M 6,940Scope 1 Intensity: 0.49 tCO2e/$MOtsuka HoldingsYear: 2024Scope 1: 368,733 tCO2eRevenue: $M 14,840Scope 1 Intensity: 24.85 tCO2e/$MSMSYear: 2023Scope 1: 220 tCO2eRevenue: $M 343Scope 1 Intensity: 0.64 tCO2e/$MAstellas PharmaYear: 2024Scope 1: 52,212 tCO2eRevenue: $M 10,589Scope 1 Intensity: 4.93 tCO2e/$MTsumura & CoYear: 2021Scope 1: 39,385 tCO2eRevenue: $M 1,055Scope 1 Intensity: 37.32 tCO2e/$MDaiichi SankyoYear: 2024Scope 1: 91,836 tCO2eRevenue: $M 10,576Scope 1 Intensity: 8.68 tCO2e/$MNNNippon ShinyakuYear: 2023Scope 1: 4,366 tCO2eRevenue: $M 1,082Scope 1 Intensity: 4.03 tCO2e/$MHikari TsushinYear: 2024Scope 1: 1,102 tCO2eRevenue: $M 3,975Scope 1 Intensity: 0.28 tCO2e/$MAlfresa HoldingsYear: 2025Scope 1: 31,360 tCO2eRevenue: $M 19,746Scope 1 Intensity: 1.59 tCO2e/$MTakeda PharmaceuticalYear: 2024Scope 1: 273,000 tCO2eRevenue: $M 28,155Scope 1 Intensity: 9.70 tCO2e/$MMMMedipal HoldingsYear: 2024Scope 1: 31,081 tCO2eRevenue: $M 23,500Scope 1 Intensity: 1.32 tCO2e/$MOlympusYear: 2025Scope 1: 24,120 tCO2eRevenue: $M 6,650Scope 1 Intensity: 3.63 tCO2e/$MKyowa KirinYear: 2024Scope 1: 16,133 tCO2eRevenue: $M 3,157Scope 1 Intensity: 5.11 tCO2e/$MAIN HoldingsYear: 2025Scope 1: 2,300 tCO2eRevenue: $M 3,193Scope 1 Intensity: 0.72 tCO2e/$MKaken PharmaceuticalYear: 2023Scope 1: 11,069 tCO2eRevenue: $M 548Scope 1 Intensity: 20.20 tCO2e/$MSumitomo PharmaYear: 2024Scope 1: 23,101 tCO2eRevenue: $M 2,077Scope 1 Intensity: 11.12 tCO2e/$MMMMedical Data VisionYear: 2024Scope 1: 13 tCO2eRevenue: $M 38Scope 1 Intensity: 0.35 tCO2e/$M

How does Medical Data Vision's GHG emissions intensity compare to its peers?

In 2024, Medical Data Vision reported a Scope 1 emissions intensity of 0.35 tCOâ‚‚e per millions USD. Compared to the peer group median of 4.03, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Medical Data Vision rank on GHG emissions intensity within its industry?

In 2024, Medical Data Vision ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

This places Medical Data Vision among the top performers, with one of the lowest emissions intensities relative to peers.a

Insights into Medical Data Vision's Total Carbon Footprint

In 2024, Medical Data Vision reported a total carbon footprint of 5,016 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 49.37% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Medical Data Vision's total carbon footprint was Scope 3 emissions, accounting for 94.18% of the company's total carbon footprint, followed by Scope 2 emissions at 5.56%.a

Want Full Access to Medical Data Vision's GHG Emissions Dataset?
Sign Up